A lot of people would change some of those things to make their lives easier, but not us,” adds Phil Lord, the other half of ...

A clinical trial led by University of Auckland researchers found that high-intensity therapy for patients begun within two weeks of a stroke did not improve hand and arm recovery beyond standard care.

PCWorld reports that Arm has launched its first chip, the Arm AI CPU, marking a major shift from licensing intellectual property to manufacturing silicon directly. The processor features 136 Neoverse ...

CNBC got an exclusive first look at Arm's first ever in-house chip, the AGI CPU, purpose-built for running AI inference in data centers. Meta is the first official customer for the new chip, with ...

Arm Holdings has had a rocky road since going public in 2023 as a chip designer with deep exposure to the global smartphone market. While that market isn’t doing too hot these days, Arm’s ...

Aliens have invaded the news again. Last month, two US presidents weighed in on the topic in rapid succession, managing to make a public that was already obsessed with extraterrestrials even more so.

Alien: Earth received glowing reviews from fans and critics when it touched down on FX last August, and it didn't take long before we learned that Season 2 was officially in the works. That news came ...

After FX confirmed Alien: Earth Season 2 last year, the hit science fiction show’s executive producer, Dana Gonzales, gave fans an exciting update regarding the upcoming installment’s progress. In a ...

Scientists find one popular diet that helps lower stroke risk in women. In a recent meta-analysis, researchers found that those who followed the Mediterranean diet had a lower stroke risk. A ...

Former US President Barack Obama said he’s seen no evidence that aliens have made contact with Earth, clarifying his position on extraterrestrials after comments he made in a podcast went viral. Obama ...

Targeted therapy of the ipsilesional, or “good” arm, improved motor function, including control and speed, in chronic stroke survivors with severe paresis. In a small randomized clinical trial ...

The National Institutes of Health (NIH) halted a treatment arm of Bayer and Johnson & Johnson’s Xarelto (rivaroxaban) in a phase 3 stroke prevention trial after an independent committee flagged safety ...